Arteris (AIP) Posted Record Q2 Results, Is The Valuation Gap Still Compelling?

Why Arteris Stock Is Back In Focus After Q2 Earnings

Arteris (AIP) is drawing fresh attention after reporting record annual contract value and second quarter revenue, while also raising new capital and announcing a change in its chief financial officer.

See our latest analysis for Arteris.

Despite the strong Q2 update and CFO transition, Arteris shares have cooled off recently, with the 7 day share price return down 12.75% and the 30 day share price return down 17.42%. Even so, the year to date share price return of 77.09% and the 3 year total shareholder return of more than 3x indicate that longer term momentum has been strong.

If Arteris has put AI focused chip design back on your radar, this may be a moment to look at other opportunities in the space using the 30 AI small caps.

Bulls point to Arteris' record contract value, AI exposure and sharp share price gain this year. Bears focus on the widening losses and recent pullback. Which side does the current valuation lean toward next?

Most Popular Narrative: 33% Undervalued

The most followed narrative on Arteris compares a fair value of $41 to the last close at $27.59, which frames the stock as materially discounted and heavily tied to AI and chiplet demand.

The ongoing industry transition to chiplet-based and heterogeneous integration architectures is expanding Arteris' addressable market, with chiplet-related design starts expected to rise from 5% to 30% in coming years; this structural trend is cited as supporting both higher sales volume and increased average selling prices, with potential implications for future top-line revenue.

Read the complete narrative.

Want to see what underpins that gap between price and fair value for Arteris? The narrative leans on brisk revenue expansion, rising contract visibility, and a steep future earnings ramp supported by a premium earnings multiple. Curious which specific growth and margin assumptions have to line up to justify that outcome?

Result: Fair Value of $41 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, the Arteris story also carries real risk, including ongoing losses and dependence on a few large AI and data center customers, which could affect future royalty timing.

Find out about the key risks to this Arteris narrative.

Another View On Arteris Valuation

The first narrative for Arteris references a fair value of $41 based on analyst expectations. A different perspective comes from our DCF model, which calculates a future cash flow value of $52.15 and indicates the stock is trading at a discount. Which set of assumptions appears more realistic to you?

Look into how the SWS DCF model arrives at its fair value.

Next Steps

With both optimism and concern running through the Arteris story, it makes sense to review the data yourself and move quickly to form your own view by weighing its 3 key rewards and 4 important warning signs.

Looking For More Investment Ideas Beyond Arteris?

If Arteris has you thinking more seriously about where to put new money to work, do not overlook other stocks that could match your goals and risk comfort.

• Target value opportunities by scanning companies that combine quality fundamentals with attractive pricing using the 51 high quality undervalued stocks.
• Strengthen your income stream by checking out stocks that offer reliable payouts through the 11 dividend fortresses.
• Protect your capital by focusing on companies with steadier profiles using the 88 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com